Martingale Asset Management L P Harmony Biosciences Holdings, Inc. Transaction History
Martingale Asset Management L P
- $3.87 Billion
- Q1 2025
A detailed history of Martingale Asset Management L P transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Martingale Asset Management L P holds 45,712 shares of HRMY stock, worth $1.72 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
45,712
Previous 37,599
21.58%
Holding current value
$1.72 Million
Previous $1.29 Million
17.32%
% of portfolio
0.04%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding HRMY
# of Institutions
281Shares Held
45MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$248 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$219 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$176 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$59.2 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$48.4 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.22B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...